World Health Matters (New Zealand): Tobacco taxes work, eventually
by Gary Finnegan: Annual 10% tobacco tax increases in New Zealand over the next 20 years should lead to health gains, net health system cost savings and modest… read more.
by Gary Finnegan: Annual 10% tobacco tax increases in New Zealand over the next 20 years should lead to health gains, net health system cost savings and modest… read more.
by Gary Finnegan: Home births lead to higher infant mortality than hospital births, at least for mothers living in poorer areas, according to a new Dutch study which… read more.
by Gary Finnegan: Preliminary findings presented at an international TB vaccine conference suggest older people are contributing to TB rates in China. Researchers say the development and introduction… read more.
by Gary Finnegan: The question of whether vaccines cause autism may have been settled long ago but the debate on how to share this message with the public… read more.
by Gary Finnegan: The European Medicines Agency is waging a fierce battle against the EU’s own employment court over the controversial 2011 appointment of its former Executive Director.
by Gary Finnegan: The European Medicines Agency wants to get new medicines to patients quicker where there is a clear unmet medical need. The move could also see… read more.
by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.
by Gary Finnegan: A new study has revealed a number of factors that appear to predict a child’s risk of developing ankylosing spondylitis (AS).
by Gary Finnegan: Peanut and nut intake appear to lower mortality rates from major diseases, according to a new study, but peanut butter has no shown any protective… read more.
by Gary Finnegan: People with terminal cancer often require palliative care in the late stages of their lives. This branch of medicine has long been lauded for the… read more.
by Gary Finnegan: Rapid weight loss can lead to a loss of bone mass and an increased risk of bone fractures. A study by University of Copenhagen, Hvidovre… read more.
by Gary Finnegan: Keytruda (pembrolizumab) has been recommended by the European Medicines Agency (EMA) as monotherapy for the treatment of adult patients with advanced melanoma that cannot be… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
